506 related articles for article (PubMed ID: 26810656)
1. Ebselen, a Small-Molecule Capsid Inhibitor of HIV-1 Replication.
Thenin-Houssier S; de Vera IM; Pedro-Rosa L; Brady A; Richard A; Konnick B; Opp S; Buffone C; Fuhrmann J; Kota S; Billack B; Pietka-Ottlik M; Tellinghuisen T; Choe H; Spicer T; Scampavia L; Diaz-Griffero F; Kojetin DJ; Valente ST
Antimicrob Agents Chemother; 2016 Apr; 60(4):2195-208. PubMed ID: 26810656
[TBL] [Abstract][Full Text] [Related]
2. A HTRF based competitive binding assay for screening specific inhibitors of HIV-1 capsid assembly targeting the C-Terminal domain of capsid.
Zhang DW; Luo RH; Xu L; Yang LM; Xu XS; Bedwell GJ; Engelman AN; Zheng YT; Chang S
Antiviral Res; 2019 Sep; 169():104544. PubMed ID: 31254557
[TBL] [Abstract][Full Text] [Related]
3. The capsid protein of human immunodeficiency virus: designing inhibitors of capsid assembly.
Neira JL
FEBS J; 2009 Nov; 276(21):6110-7. PubMed ID: 19825045
[TBL] [Abstract][Full Text] [Related]
4. Cell Type-Dependent Escape of Capsid Inhibitors by Simian Immunodeficiency Virus SIVcpz.
Twizerimana AP; Scheck R; Becker D; Zhang Z; Wammers M; Avelar L; Pflieger M; Häussinger D; Kurz T; Gohlke H; Münk C
J Virol; 2020 Nov; 94(23):. PubMed ID: 32907979
[TBL] [Abstract][Full Text] [Related]
5. Natural-product-library-based screening for discovery of capsid C-terminal domain targeted HIV-1 inhibitors.
Zhang DW; Luo RH; Xu L; Yang LM; Xu XS; Zheng YT; Luo H
Int J Antimicrob Agents; 2020 Apr; 55(4):105926. PubMed ID: 32092396
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting early-stage events in HIV-1 replication by small-molecule targeting of the HIV-1 capsid.
Kortagere S; Madani N; Mankowski MK; Schön A; Zentner I; Swaminathan G; Princiotto A; Anthony K; Oza A; Sierra LJ; Passic SR; Wang X; Jones DM; Stavale E; Krebs FC; Martín-García J; Freire E; Ptak RG; Sodroski J; Cocklin S; Smith AB
J Virol; 2012 Aug; 86(16):8472-81. PubMed ID: 22647699
[TBL] [Abstract][Full Text] [Related]
7. Specific Inhibitors of HIV Capsid Assembly Binding to the C-Terminal Domain of the Capsid Protein: Evaluation of 2-Arylquinazolines as Potential Antiviral Compounds.
Machara A; Lux V; Kožíšek M; Grantz Šašková K; Štěpánek O; Kotora M; Parkan K; Pávová M; Glass B; Sehr P; Lewis J; Müller B; Kräusslich HG; Konvalinka J
J Med Chem; 2016 Jan; 59(2):545-58. PubMed ID: 26685880
[TBL] [Abstract][Full Text] [Related]
8. Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilization.
Shi J; Zhou J; Shah VB; Aiken C; Whitby K
J Virol; 2011 Jan; 85(1):542-9. PubMed ID: 20962083
[TBL] [Abstract][Full Text] [Related]
9. The selenium-containing drug ebselen potently disrupts LEDGF/p75-HIV-1 integrase interaction by targeting LEDGF/p75.
Zhang DW; Yan HL; Xu XS; Xu L; Yin ZH; Chang S; Luo H
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):906-912. PubMed ID: 32228103
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of HIV-1 Maturation via Small-Molecule Targeting of the Amino-Terminal Domain in the Viral Capsid Protein.
Wang W; Zhou J; Halambage UD; Jurado KA; Jamin AV; Wang Y; Engelman AN; Aiken C
J Virol; 2017 May; 91(9):. PubMed ID: 28202766
[TBL] [Abstract][Full Text] [Related]
11. Identification of an Antiretroviral Small Molecule That Appears To Be a Host-Targeting Inhibitor of HIV-1 Assembly.
Reed JC; Solas D; Kitaygorodskyy A; Freeman B; Ressler DTB; Phuong DJ; Swain JV; Matlack K; Hurt CR; Lingappa VR; Lingappa JR
J Virol; 2021 Jan; 95(3):. PubMed ID: 33148797
[TBL] [Abstract][Full Text] [Related]
12. Rationally designed interfacial peptides are efficient in vitro inhibitors of HIV-1 capsid assembly with antiviral activity.
Bocanegra R; Nevot M; Doménech R; López I; Abián O; Rodríguez-Huete A; Cavasotto CN; Velázquez-Campoy A; Gómez J; Martínez MÁ; Neira JL; Mateu MG
PLoS One; 2011; 6(9):e23877. PubMed ID: 21931621
[TBL] [Abstract][Full Text] [Related]
13. Antiviral activity of α-helical stapled peptides designed from the HIV-1 capsid dimerization domain.
Zhang H; Curreli F; Zhang X; Bhattacharya S; Waheed AA; Cooper A; Cowburn D; Freed EO; Debnath AK
Retrovirology; 2011 May; 8():28. PubMed ID: 21539734
[TBL] [Abstract][Full Text] [Related]
14. Identification of a small molecule HIV-1 inhibitor that targets the capsid hexamer.
Xu JP; Branson JD; Lawrence R; Cocklin S
Bioorg Med Chem Lett; 2016 Feb; 26(3):824-828. PubMed ID: 26747394
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 Capsid Inhibitors as Antiretroviral Agents.
Thenin-Houssier S; Valente ST
Curr HIV Res; 2016; 14(3):270-82. PubMed ID: 26957201
[TBL] [Abstract][Full Text] [Related]
16. Microplate-based assay for identifying small molecules that bind a specific intersubunit interface within the assembled HIV-1 capsid.
Halambage UD; Wong JP; Melancon BJ; Lindsley CW; Aiken C
Antimicrob Agents Chemother; 2015 Sep; 59(9):5190-5. PubMed ID: 26077250
[TBL] [Abstract][Full Text] [Related]
17. Debio-025 inhibits HIV-1 by interfering with an early event in the replication cycle.
Daelemans D; Dumont JM; Rosenwirth B; De Clercq E; Pannecouque C
Antiviral Res; 2010 Feb; 85(2):418-21. PubMed ID: 19857522
[TBL] [Abstract][Full Text] [Related]
18. Dendrimers as potential inhibitors of the dimerization of the capsid protein of HIV-1.
Doménech R; Abian O; Bocanegra R; Correa J; Sousa-Herves A; Riguera R; Mateu MG; Fernandez-Megia E; Velázquez-Campoy A; Neira JL
Biomacromolecules; 2010 Aug; 11(8):2069-78. PubMed ID: 20690715
[TBL] [Abstract][Full Text] [Related]
19. Complementary Assays Reveal a Low Level of CA Associated with Viral Complexes in the Nuclei of HIV-1-Infected Cells.
Hulme AE; Kelley Z; Foley D; Hope TJ
J Virol; 2015 May; 89(10):5350-61. PubMed ID: 25741002
[TBL] [Abstract][Full Text] [Related]
20. Novel inhibitor binding site discovery on HIV-1 capsid N-terminal domain by NMR and X-ray crystallography.
Goudreau N; Lemke CT; Faucher AM; Grand-Maître C; Goulet S; Lacoste JE; Rancourt J; Malenfant E; Mercier JF; Titolo S; Mason SW
ACS Chem Biol; 2013 May; 8(5):1074-82. PubMed ID: 23496828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
